Henric Bjarke
2022
In 2022, Henric Bjarke earned a total compensation of $958.9K as Former Senior Vice President and Chief Operating Officer at Inozyme Pharma, a 29% decrease compared to previous year.
Compensation breakdown
| Option Awards | $491,999 |
|---|---|
| Salary | $458,615 |
| Other | $8,282 |
| Total | $958,896 |
Bjarke received $492K in option awards, accounting for 51% of the total pay in 2022.
Bjarke also received $458.6K in salary and $8.3K in other compensation.
Rankings
In 2022, Henric Bjarke's compensation ranked 3,107th out of 5,697 executives tracked by ExecPay. In other words, Bjarke earned more than 45.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,107 out of 5,697 | 46th |
Division Manufacturing | 1,745 out of 3,099 | 44th |
Major group Chemicals And Allied Products | 819 out of 1,406 | 42nd |
Industry group Drugs | 764 out of 1,307 | 42nd |
Industry Pharmaceutical Preparations | 554 out of 953 | 42nd |
Source: SEC filing on April 27, 2023.
Bjarke's colleagues
We found two more compensation records of executives who worked with Henric Bjarke at Inozyme Pharma in 2022.